METRO REPORTS 2026 FOURTH QUARTER RESULTS
METRO REPORTS 2026 FOURTH QUARTER RESULTS |
| [18-November-2026] |
MONTRÉAL, Nov. 18, 2026 /CNW/ -- METRO INC. (TSX: MRU) today announced its results for the fourth quarter of Fiscal 2026 ended September 26, 2026.
2026 FOURTH QUARTER HIGHLIGHTS
FISCAL 2026 HIGHLIGHTS
PRESIDENT'S MESSAGE "Our fourth quarter results continued to be significantly impacted by the labour conflict at our produce distribution centre in Laval, which ended after six months on September 24. We have ramped up our operations and returned to normal service levels. Our focus is now on driving back customer traffic and volume to our stores. We are pleased with the progress made on our strategic priorities. We continued the expansion of our discount network with 13 store openings during the year, including four in the quarter. The evolution of our e-commerce fulfillment model which started at the beginning of the quarter is in progress and should be completed by the end of the first quarter(2). On the pharmacy side, we are pleased with the continued momentum of our business which delivered strong same-store sales(1) growth in both prescription drugs and front-store sales(1). I have strong confidence in our people, our banners and our strategy. While the economic environment remains challenging, METRO is well positioned to build on its solid foundation and continue creating sustainable long-term value for our customers, employees and shareholders(2)", declared Marc Giroux, President and Chief Executive Officer. OPERATING RESULTS SALES Sales in the fourth quarter of Fiscal 2026 ended on September 26, 2026 were $5,179.5 million, up 1.4% versus the fourth quarter of the prior year which ended on September 27, 2025. Sales were positively impacted by new store openings, but were unfavorably impacted by the labour conflict at our produce distribution centre in Laval and its consequences on our food retail network in Quebec. Food same-store sales(1) were down 1.9% in the fourth quarter of Fiscal 2026 (2025 — up 1.6%). Online food sales(1) were up 3.3% versus last year (2025 — 19.8%). Our food basket inflation was below the reported CPI of 2.4% for food purchased from stores. Pharmacy same-store sales(1) were up 5.5% (2025 — 4.8%), with a 6.5% increase in prescription drugs sales(1) and a 3.1% increase in front-store sales(1), primarily driven by over-the-counter products, cosmetics and seasonal products. Sales for Fiscal 2026 totalled $22,548.7 million, up 2.5% compared to $22,006.7 million for Fiscal 2025. OPERATING INCOME BEFORE DEPRECIATION AND AMORTIZATION, IMPAIRMENT OF ASSETS AND INVENTORIES WRITE-DOWN This earnings measurement excludes financial costs, taxes, depreciation and amortization, impairment of assets and inventories write-down. Gross margin(1) for the fourth quarter and Fiscal 2026 were 19.2% and 19.4% respectively versus 20.0% and 19.9% for the corresponding periods of 2025. Gross profit for the fourth quarter and Fiscal 2026 were unfavorably impacted by $40 million and $127 million respectively of estimated lost profit and incremental direct costs related to a labour conflict at our produce distribution centre in Laval. Operating expenses as a percentage of sales for the fourth quarter of Fiscal 2026 were 10.7% versus 10.5% for the corresponding quarter of 2025. For Fiscal 2026, operating expenses as a percentage of sales were 10.5% versus 10.4% for Fiscal 2025. The fourth quarter and Fiscal 2026 included $2 million and $5 million respectively of incremental direct costs related to the labour conflict at our produce distribution centre in Laval. Asset disposals in the fourth quarter of 2026 generated gains of $15.0 million, including $14.7 million related to the sale of Première Moisson Group Inc.'s commercial bakery manufacturing operations located in Baie-D'Urfé. In the fourth quarter of 2025, asset disposals generated losses of $1.9 million. Operating income before depreciation and amortization, impairment of assets and inventories write-down for the fourth quarter of Fiscal 2026 totalled $454.2 million, or 8.8% of sales, a decrease of 6.3% versus the corresponding quarter of Fiscal 2025. Excluding the gain related to the sale of Première Moisson Group Inc.'s commercial bakery manufacturing operations, operating income before depreciation and amortization, impairment of assets and inventories write-down as a percentage of sales would be 8.5%, a decrease of 10.4% from the prior year. Operating income before depreciation and amortization, impairment of assets and inventories write-down for Fiscal 2026 totalled $2,001.1 million, or 8.9% of sales, down 3.9% versus Fiscal 2025. Management estimates that the labour conflict at our produce distribution centre in Laval negatively impacted the fourth quarter and Fiscal 2026 results by $42 million and $132 million respectively. This figure is based on estimated lost sales and associated estimated lost margins, realized inventory losses and incremental direct costs including third party logistics and security services. DEPRECIATION AND AMORTIZATION Total depreciation and amortization expense for the fourth quarter of Fiscal 2026 was $143.7 million versus $139.8 million for the corresponding quarter of 2025. The increase in depreciation and amortization expense is mainly due to the increase in the retail network investments, including right-of-use assets, and technology investments. For Fiscal 2026, total depreciation and amortization expense was $625.2 million versus $594.4 million for Fiscal 2025. IMPAIRMENT OF ASSETS The Corporation recognized impairment of assets of $1.8 million during the fourth quarter of Fiscal 2026 regarding retail operations of the Première Moisson Group Inc. The impairment of assets related primarily to property and equipment, right-of-use assets, and leasehold improvements. NET FINANCIAL COSTS Net financial costs for the fourth quarter of Fiscal 2026 were $39.3 million compared with $34.4 million in the corresponding quarter of 2025. The increase in net financial costs is mainly due to higher interest expense on net debt. For Fiscal 2026, net financial costs were $164.4 million compared with $143.8 million for Fiscal 2025. The increase in net financial costs is mainly due to higher interest expense on net debt and to interest received in 2025 in connection with various tax matters. INCOME TAXES The income tax expense of $67.5 million for the fourth quarter of Fiscal 2026 represented an effective tax rate of 25.1% compared with an income tax expense of $69.0 million and an effective tax rate of 24.1% for the fourth quarter of Fiscal 2025. The income tax expense of $291.5 million for Fiscal 2026 and $300.7 million for Fiscal 2025 represented effective tax rates of 24.8% and 22.8% respectively. The increase in the effective tax rate in 2026 is mainly attributable to a favourable $20.6 million income tax adjustment in respect of prior years in the first quarter of 2025. The provincial tax holiday on a large investment project was $23.6 million for Fiscal 2026 compared with $23.5 million for Fiscal 2025. NET EARNINGS AND ADJUSTED NET EARNINGS(1) Net earnings for the fourth quarter of Fiscal 2026 were $201.9 million compared with $217.0 million for the corresponding quarter of 2025, while fully diluted net earnings per share were $0.97 compared with $1.00 in 2025, down 7.0% and 3.0% respectively. Excluding the specific items shown in the table below, adjusted net earnings(1) for the fourth quarter of Fiscal 2026 totalled $201.8 million compared with $246.0 million for the corresponding quarter of 2025, and adjusted fully diluted net earnings per share(1) for the fourth quarter of Fiscal 2026 were $0.97, versus $1.13 in 2025, down 18.0% and 14.2% respectively. Net earnings were not adjusted for the labour conflict at our produce distribution centre in Laval which had an estimated unfavorable impact of $31 million after-tax or $0.16 per share. Net earnings for Fiscal 2026 were $886.1 million compared with $1,019.5 million for Fiscal 2025, while fully diluted net earnings per share were $4.18 compared with $4.63 in 2025, down 13.1% and 9.7% respectively. Excluding the specific items shown in the table below, adjusted net earnings(1) for Fiscal 2026 totalled $949.6 million compared with $1,049.8 million for Fiscal 2025, and adjusted fully diluted net earnings per share(1) were $4.48 in 2026 versus $4.77 in 2025, down 9.5% and 6.1% respectively. Net earnings were not adjusted for the labour conflict at our produce distribution centre in Laval which had an estimated unfavorable impact of $97 million after-tax or $0.48 per share. Net earnings and fully diluted net earnings per share (EPS) adjustments(1)
NORMAL COURSE ISSUER BID PROGRAM Under the current normal course issuer bid program, the Corporation may repurchase up to 10,000,000 of its Common Shares between November 27, 2025 and November 26, 2026. As at November 6, 2026, the Corporation has repurchased 6,800,000 Common Shares at an average price of $93.53, for a total consideration of $636.0 million. The Corporation intends(2) to renew its normal course issuer bid program as an additional option for using excess funds. DIVIDENDS On September 28, 2026, the Board of Directors declared a quarterly dividend of $0.4075 per share, the same amount declared in the previous quarter. FORWARD-LOOKING INFORMATION We have used, throughout this report, different statements that could, within the context of regulations issued by the Canadian Securities Administrators, be construed as being forward-looking information. In general, any statement contained herein that does not constitute a historical fact may be deemed a forward-looking statement. Expressions such as "expect", "should", "continue", "intend" and other similar expressions are generally indicative of forward-looking statements. The forward-looking statements contained herein are based upon certain assumptions regarding the Canadian food and pharmaceutical industries, the general economy, our annual budget, as well as our 2027 action plan. These forward-looking statements do not provide any guarantees as to the future performance of the Corporation and are subject to potential risks, known and unknown, as well as uncertainties that could cause the outcome to differ significantly. Risk factors that could cause actual results or events to differ materially from our expectations as expressed in, or implied by, our forward-looking statements are described and discussed under the "Risk Management" section in our Annual Report 2025. We believe these statements to be reasonable and pertinent as at the date of publication of this report and represent our expectations. The Corporation does not intend to update any forward-looking statement contained herein, except as required by applicable law. NON-GAAP AND OTHER FINANCIAL MEASUREMENTS In addition to the International Financial Reporting Standards (IFRS) measurements provided, we have included certain non-GAAP and other financial measurements. These measurements are presented for information purposes only. They do not have a standardized meaning prescribed by IFRS and therefore may not be comparable to similar measurements presented by other public companies. National Instrument 52-112 Non-GAAP and Other Financial Measures Disclosure sets out specific disclosure requirements for non-GAAP financial measures, non-GAAP ratios, and other financial measures, which are capital management measures, supplementary financial measures, and total of segments measures, as defined in the Instrument (together the "specified financial measures"). The specified financial measures we disclose in our documents made available to the public are presented by measurement categories below. NON-GAAP FINANCIAL MEASURES Adjusted earnings before net financial costs and income taxes is a non-GAAP financial measurement that, with respect to its composition, is adjusted to exclude net financial costs and special items from the composition of the most directly comparable financial measure disclosed in our consolidated financial statements, which is earnings before income taxes. Special items may include acquisition and restructuring charges, gains or losses on the disposal of investments, and amortization and impairment losses of intangible assets resulting from a business acquisition. Adjusted net earnings is a non-GAAP financial measurement that, with respect to its composition, is adjusted to exclude special items from the composition of the most directly comparable financial measure disclosed in our consolidated financial statements, which is net earnings. Special items may include acquisition and restructuring charges, gains or losses on the disposal of investments, amortization and impairment losses of intangible assets resulting from a business acquisition, and significant prior-year tax adjustments. For measurements depicting financial performance, we believe that presenting earnings adjusted for these items, which are not necessarily reflective of the Corporation's performance, leaves readers of financial statements better informed thus enabling them to better perform trend analysis, evaluate the Corporation's financial performance and assess its future outlook. Adjusting for these items does not imply that they are non-recurring. NON-GAAP RATIOS Adjusted fully diluted net earnings per share is a non-GAAP ratio in which a non-GAAP financial measure is used as one or more of its components. The non-GAAP component used is adjusted net earnings(1). Adjusted fully diluted net earnings per share is calculated by dividing the adjusted net earnings(1) attributable to equity holders of the parent by the weighted average number of Common Shares outstanding during the year, adjusted to reflect all potential dilutive shares. We believe that presenting this ratio, in which a non-GAAP financial measurement is used as one or more of its components, leaves readers of financial statements better informed as to the current period and corresponding prior year's period's performance, thus enabling them to better perform trend analysis, evaluate the Corporation's financial performance and assess its future outlook. Adjusting for these items does not imply that they are non-recurring. SUPPLEMENTARY FINANCIAL MEASURES The supplementary financial measures listed below are, or are intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of the Corporation. Food same-store sales are defined as comparable retail sales of stores with more than 52 consecutive weeks of operations, including relocated, expanded and renovated locations. Food same-store sales is a measure based on all stores in our network, including those whose sales are not included in the Corporation's consolidated financial statements. Online food sales are the sum of sales made from all our online channels. Pharmacy same-store sales (including total, front-store and prescription drugs) are defined as comparable retail sales of stores with more than 52 consecutive weeks of operations, including relocated, expanded and renovated locations. Pharmacy same-store sales do not form part of the Corporation's consolidated financial statements because the pharmacies are held by pharmacist owners. Gross margin ratio is calculated by dividing gross profit by sales. OUTLOOK(2) The labour conflict at our produce distribution centre in Laval ended on September 24, 2026, and we have ramped up our operations and returned to normal service levels. Our focus is now on driving back customer traffic and volume to our stores and after four weeks in the first quarter, our food same store sales(1) remain negative but have started to improve. As we enter Fiscal 2027, we continue to advance the expansion of our discount store network. Following the announcement of our Ontario store network restructuring in the third quarter, we completed the first of 10 planned Metro-to-Food Basics conversions in the fourth quarter, with the remaining nine planned for this year. Combined with seven new discount store openings planned for Fiscal 2027, these initiatives will expand our discount footprint and strengthen our ability to meet evolving customer trends. On the pharmacy side, we are very well positioned for growth including capturing the opportunity related to the upcoming expansion in the scope of practice of pharmacists in Québec. Despite the near-term macro-economic challenges, we remain confident in the strength of our food and pharmacy businesses and our competitive positioning. We are steadfast in our efforts to deliver compelling value to our customers through effective merchandising programs, strong private labels, our Moi program and consistent execution at store level. With a disciplined focus on execution and on our strategic priorities, we are well positioned to continue creating long-term value for our shareholders. CONFERENCE CALL Financial analysts and institutional investors are invited to participate in a conference call for the 2026 fourth quarter results at 9:00 a.m. (EST) today, November 18, 2026. To access the conference call, please dial 1 (800) 990-4777. The media and investing public may access this conference via a listen mode only. Notice to readers: METRO INC. fourth quarter of 2026 interim condensed consolidated financial statements and management's discussion and analysis are available on the Internet at www.corpo.metro.ca - Corporate Site - Investors - 2026 Quarterly Results - 2026 Fourth Quarter Results.
SOURCE METRO INC. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company Codes: Toronto:MRU | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||












